In Johnson & Johnson’s second quarter 2014 earnings call today, one analyst asked chairman and CEO Alex Gorsky for his take on Medtronic’s $42.9 billion acquisition of Covidien last month.
Hey, check out all the research scientist jobs. Post your resume today!
